← All companies

BGLC

BioNexus Gene Lab Corp.

BGLC Nasdaq Services-Medical Laboratories EDGAR ↗

$1.43

+0.11 +8.33%

Key statistics

from XBRL data in SEC filings

Market cap

$3.46M

Revenue (TTM)

$5.31M

Net income (TTM)

-$2.90M

EPS (TTM)

$-1.31

P/E ratio

—

Dividend yield

—

Free cash flow

-$1.88M

Cash

$1.34M

Total assets

$9.04M

Gross margin

14.0%

52-week range

$1.07 – $6.78

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Other events Jul 28, 2026 8-K Other events Jun 5, 2026 10-Q Quarter ended 2026-03-31 May 15, 2026 10-K Fiscal year ended 2025-12-31 Apr 14, 2026 8-K Regulation FD disclosure; Other events Mar 17, 2026 8-K Other events Feb 23, 2026 8-K Other events Feb 3, 2026 8-K Shareholder vote results Dec 30, 2025 8-K Other events Dec 23, 2025 8-K Entered a material agreement; Unregistered sale of equity; Regulation FD disclosure Dec 2, 2025 10-Q Quarter ended 2025-09-30 Nov 14, 2025 8-K Entered a material agreement; Regulation FD disclosure Nov 13, 2025 8-K Entered a material agreement; Unregistered sale of equity; Regulation FD disclosure Nov 12, 2025 8-K Regulation FD disclosure Oct 23, 2025 10-Q Quarter ended 2025-06-30 Aug 18, 2025 8-K Regulation FD disclosure Jul 30, 2025 8-K Director or officer change Jun 23, 2025 10-Q Quarter ended 2025-03-31 May 15, 2025 8-K Delisting notice or listing-rule failure; Regulation FD disclosure Apr 30, 2025 10-K/A Fiscal year ended 2024-12-31 Apr 29, 2025 10-K Fiscal year ended 2024-12-31 Apr 15, 2025 8-K Modified rights of security holders Apr 10, 2025 8-K Modified rights of security holders; Amended charter or bylaws Apr 3, 2025 8-K Shareholder vote results Mar 25, 2025 8-K Regulation FD disclosure Mar 7, 2025 8-K Other events Mar 5, 2025 8-K Unregistered sale of equity; Modified rights of security holders; Amended charter or bylaws Feb 14, 2025 8-K Delisting notice or listing-rule failure Jan 2, 2025 10-Q Quarter ended 2024-09-30 Nov 15, 2024 8-K Delisting notice or listing-rule failure; Director or officer change Nov 8, 2024 8-K Director or officer change Oct 15, 2024 8-K Shareholder vote results; Other events Oct 10, 2024 8-K Entered a material agreement; Other events Sep 25, 2024 8-K Regulation FD disclosure Sep 18, 2024 8-K Regulation FD disclosure Sep 12, 2024 8-K Amended charter or bylaws Sep 5, 2024 8-K Regulation FD disclosure Aug 28, 2024 8-K Entered a material agreement; Regulation FD disclosure; Other events Aug 26, 2024 10-Q Quarter ended 2024-06-30 Aug 14, 2024 8-K/A Director or officer change Jul 5, 2024